Director Valantine Hannah sold CareDx ($CDNA) shares once on the open market in the last year for $202,600, with the most recent sale on June 18, 2025, ranking 8,378th among insiders by sales value. She also sold BridgeBio Pharma ($BBIO) shares nine times totaling $4.4 million, most recently on March 10, 2026, ranking 2,116th. Among nearly 12,000 insiders averaging $8.6 million in sales over 6.4 transactions, Hannah made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | M | Stock Option (Right to Buy) | 8671 | $0.00 | 17,343.0000 | 192,708,813 | 33.33% | 0.00% |
| March 10, 2026 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | M | Common Stock | 8671 | $27.36 | 16,534.0000 | 192,708,813 | 110.28% | 0.00% |
| March 10, 2026 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | S | Common Stock | 8671 | $72.00 | 7,863.0000 | 192,708,813 | 52.44% | 0.00% |
| Feb. 27, 2026 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | M | Stock Option (Right to Buy) | 25484 | $0.00 | 0.0000 | 192,708,813 | 100.00% | 0.01% |
| Feb. 27, 2026 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | S | Common Stock | 10900 | $67.84 | 7,863.0000 | 192,708,813 | 58.09% | 0.01% |
| Feb. 27, 2026 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | M | Common Stock | 25484 | $48.45 | 33,347.0000 | 192,708,813 | 324.10% | 0.01% |
| Feb. 27, 2026 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | S | Common Stock | 14584 | $67.08 | 18,763.0000 | 192,708,813 | 43.73% | 0.01% |
| Nov. 12, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | M | Common Stock | 25484 | $48.45 | 33,347.0000 | 192,708,813 | 324.10% | 0.01% |
| Nov. 12, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | M | Stock Option (Right to Buy) | 25484 | $0.00 | 25,484.0000 | 192,708,813 | 50.00% | 0.01% |
| Nov. 12, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | S | Common Stock | 25484 | $66.07 | 7,863.0000 | 192,708,813 | 76.42% | 0.01% |
| Dec. 29, 2021 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | P | Common Stock | 1752 | $14.24 | 5,981.0000 | 0 | 41.43% | 0.00% |
| Dec. 28, 2021 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | P | Common Stock | 796 | $13.16 | 4,229.0000 | 0 | 23.19% | 0.00% |
| Dec. 28, 2021 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | P | Common Stock | 1542 | $12.68 | 4,229.0000 | 0 | 57.39% | 0.00% |
| June 26, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | S | Common Stock | 1891 | $44.03 | 7,863.0000 | 190,188,626 | 19.39% | 0.00% |
| June 26, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | S | Common Stock | 398 | $44.13 | 9,754.0000 | 190,188,626 | 3.92% | 0.00% |
| June 26, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | S | Common Stock | 1542 | $44.01 | 7,863.0000 | 190,188,626 | 16.40% | 0.00% |
| June 26, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | S | Common Stock | 876 | $44.11 | 9,405.0000 | 190,188,626 | 8.52% | 0.00% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | A | Common Stock | 6589 | $0.00 | 11,786.0000 | 190,188,626 | 126.78% | 0.00% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | A | Stock Option (Right to Buy) | 8425 | $0.00 | 8,425.0000 | 190,188,626 | 9999.99% | 0.00% |
| June 18, 2025 | CareDx, Inc. | $CDNA | Valantine Hannah | Not found | S | Common Stock | 10570 | $19.16 | 38,994.0000 | 56,620,590 | 21.33% | 0.02% |
| June 13, 2025 | CareDx, Inc. | $CDNA | Valantine Hannah | Not found | A | Common Stock | 12103 | $0.00 | 49,564.0000 | 56,620,590 | 32.31% | 0.02% |
| June 10, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | M | Stock Option (right to buy) | 4292 | $0.00 | 34,334.0000 | 190,188,626 | 11.11% | 0.00% |
| June 10, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | S | Common Stock | 4292 | $40.00 | 5,197.0000 | 190,188,626 | 45.23% | 0.00% |
| June 10, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | M | Common Stock | 4292 | $16.75 | 9,489.0000 | 190,188,626 | 82.59% | 0.00% |
| June 4, 2025 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $PACB | Valantine Hannah | Director | A | Stock Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 297,852,228 | 9999.99% | 0.02% |
| March 6, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | S | Common Stock | 12875 | $32.58 | 5,197.0000 | 190,188,626 | 71.24% | 0.01% |
| March 6, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | M | Common Stock | 12875 | $16.75 | 18,072.0000 | 190,188,626 | 247.74% | 0.01% |
| March 6, 2025 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | M | Stock Option (right to buy) | 12875 | $0.00 | 38,626.0000 | 190,188,626 | 25.00% | 0.01% |
| June 21, 2024 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | A | Stock Option (Right to Buy) | 26014 | $0.00 | 26,014.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2024 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $PACB | Valantine Hannah | Director | A | Stock Option (right to buy) | 32179 | $0.00 | 32,179.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2024 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $PACB | Valantine Hannah | Director | A | Common Stock | 22821 | $0.00 | 22,821.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | CareDx, Inc. | $CDNA | Valantine Hannah | Not found | A | Stock Option (right to buy) | 16048 | $0.00 | 16,048.0000 | 53,764,705 | 9999.99% | 0.03% |
| June 14, 2024 | CareDx, Inc. | $CDNA | Valantine Hannah | Not found | A | Common Stock | 10570 | $0.00 | 37,461.0000 | 53,764,705 | 39.31% | 0.02% |
| June 14, 2024 | CareDx, Inc. | $CDNA | Valantine Hannah | Not found | A | Stock Option (right to buy) | 16048 | $0.00 | 16,048.0000 | 53,764,705 | 9999.99% | 0.03% |
| Feb. 15, 2024 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | M | Common Stock | 2915 | $8.45 | 8,112.0000 | 0 | 56.09% | 0.00% |
| Feb. 15, 2024 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | M | Stock Option (right to buy) | 2915 | $0.00 | 93,261.0000 | 0 | 3.03% | 0.00% |
| Feb. 15, 2024 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | S | Common Stock | 2915 | $37.75 | 5,197.0000 | 0 | 35.93% | 0.00% |
| Dec. 28, 2021 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | P | Common Stock | 1542 | $12.68 | 3,433.0000 | 0 | 81.54% | 0.00% |
| Dec. 28, 2021 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | P | Common Stock | 1891 | $13.18 | 3,655.0000 | 0 | 107.20% | 0.00% |
| Dec. 28, 2021 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | P | Common Stock | 1542 | $12.68 | 5,197.0000 | 0 | 42.19% | 0.00% |
| Dec. 28, 2021 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | P | Common Stock | 1891 | $13.18 | 1,891.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | M | Stock Option (right to buy) | 2915 | $0.00 | 96,176.0000 | 0 | 2.94% | 0.00% |
| Jan. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | M | Common Stock | 2915 | $8.45 | 4,679.0000 | 0 | 165.25% | 0.00% |
| Jan. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Not found | S | Common Stock | 2915 | $37.97 | 1,764.0000 | 0 | 62.30% | 0.00% |
| Dec. 15, 2023 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | M | Stock Option (right to buy) | 2915 | $0.00 | 99,091.0000 | 0 | 2.86% | 0.00% |
| Dec. 15, 2023 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | S | Common Stock | 2915 | $36.12 | 1,764.0000 | 0 | 62.30% | 0.00% |
| Dec. 15, 2023 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | M | Common Stock | 2915 | $8.45 | 4,679.0000 | 0 | 165.25% | 0.00% |
| Nov. 15, 2023 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | M | Common Stock | 2915 | $8.45 | 4,679.0000 | 0 | 165.25% | 0.00% |
| Nov. 15, 2023 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | M | Stock Option (right to buy) | 2915 | $0.00 | 102,006.0000 | 0 | 2.78% | 0.00% |
| Nov. 15, 2023 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | S | Common Stock | 2915 | $30.00 | 1,764.0000 | 0 | 62.30% | 0.00% |
| June 21, 2023 | BridgeBio Pharma, Inc. | $BBIO | Valantine Hannah | Director | A | Stock Option (right to buy) | 51501 | $0.00 | 51,501.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | CareDx, Inc. | $CDNA | Valantine Hannah | Director | A | Common Stock | 29136 | $0.00 | 29,136.0000 | 53,321,625 | 9999.99% | 0.05% |
| June 16, 2023 | CareDx, Inc. | $CDNA | Valantine Hannah | Director | A | Common Stock | 18844 | $0.00 | 26,891.0000 | 53,321,625 | 234.17% | 0.04% |
| Jan. 6, 2023 | CareDx, Inc. | $CDNA | Valantine Hannah | Director | A | Common Stock | 676 | $0.00 | 8,047.0000 | 53,321,625 | 9.17% | 0.00% |